Get started
Author

Anna Zimmermann

Observed names: A Zimmermann, A. Zimmermann, Anna Hayden Zimmermann, Zimmermann, A., Zimmermann, Anna, Zimmermann, Anna Sophie
Observed institutions: Leibniz University Hannover, University of Geneva, Eli Lilly (United States), Duke University, TU Dortmund University, Cornell University, University Hospital Bonn, University Hospital Heidelberg, Aarhus University Hospital, University Hospital of Geneva, VIB-KU Leuven Center for Microbiology, Duke Medical Center, Instituto de Biologia Experimental e Tecnológica, Leibniz Research Centre for Working Environment and Human Factors, Boyce Thompson Institute, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, KU Leuven
ORCID: 0000-0002-2319-2784
Observed ORCID: 0000-0002-2319-2784
OpenAlex ID: A5085034552
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, with Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients with Bladder Cancer
2006 · H. von der Maase, L. Sengelov, et al. · The Journal of Urology · 167
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer
2006 · J.T. Roberts, H. von der Maase, et al. · Annals of Oncology · 115
Pheromone sensing regulates Caenorhabditis elegans lifespan and stress resistance via the deacetylase SIR-2.1
2013 · Andreas H. Ludewig, Yevgeniy Izrayelit, et al. · Proceedings of the National Academy of Sciences · 103
Haplotype-Based Banking of Human Pluripotent Stem Cells for Transplantation: Potential and Limitations
2012 · Anna Zimmermann, Olivier Preynat-Seauve, et al. · Stem Cells and Development · 65
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype
2011 · Silvia Selinski, Meinolf Blaszkewicz, et al. · Pharmacogenetics and Genomics · 59
Mutagenesis techniques for evolutionary engineering of microbes – exploiting CRISPR-Cas, oligonucleotides, recombinases, and polymerases
2024 · Anna Zimmermann, Julian E. Prieto-Vivas, et al. · Trends in Microbiology · 50
PDF
Combinatorial optimization of gene expression through recombinase-mediated promoter and terminator shuffling in yeast
2024 · Charlotte Cautereels, Jolien Smets, et al. · Nature Communications · 47
PDF
A Cas3-base editing tool for targetable in vivo mutagenesis
2023 · Anna Zimmermann, Julian E. Prieto-Vivas, et al. · Nature Communications · 47
PDF
Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk
2010 · Marie-Louise Lehmann, Silvia Selinski, et al. · Archives of Toxicology · 43
Validation of the Functional Assessment of Cancer Therapy–Lymphoma (FACT-LYM) in Patients with Relapsed/Refractory Mantle Cell Lymphoma
2008 · Gebra Cuyun Carter, Astra M Liepa, et al. · Blood · 41
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk
2012 · Silvia Selinski, Marie-Louise Lehmann, et al. · Archives of Toxicology · 40
Orthogonal LoxPsym sites allow multiplexed site-specific recombination in prokaryotic and eukaryotic hosts
2024 · Charlotte Cautereels, Jolien Smets, et al. · Nature Communications · 39
PDF
Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis.
2003 · Q Liao, J Kleeff, et al. · PubMed · 34
Lymphocyte subpopulations in healthy newborn infants: Comparison of cord blood values with values five days after birth
1993 · M. Raes, P. Alliet, et al. · The Journal of Pediatrics · 29
Zmb HLH 80 and Zmb HLH 90 transcription factors act antagonistically and contribute to regulate PEPC 1cell‐specific gene expression in maize
2019 · Alicja M. Górska, Paulo Gouveia, et al. · The Plant Journal · 21
PDF
UDP-Glucuronosyltransferase 2B7 C802T(His268Tyr) Polymorphism in Bladder Cancer Cases
2008 · Anna Zimmermann, Meinolf Blaszkewicz, et al. · Journal of Toxicology and Environmental Health · 21
Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene
2011 · Silvia Selinski, Marie-Louise Lehmann, et al. · Archives of Toxicology · 19
Odor Thresholds and Breathing Changes of Human Volunteers as Consequences of Sulphur Dioxide Exposure Considering Individual Factors
2011 · Stefan Kleinbeck, Michael Schäper, et al. · Safety and Health at Work · 13
PDF
ZmOrphan94 Transcription Factor Downregulates ZmPEPC1 Gene Expression in Maize Bundle Sheath Cells
2021 · Alicja M. Górska, Paulo Gouveia, et al. · Frontiers in Plant Science · 11
PDF
Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection
2013 · Sylvia Brost, Anna Zimmermann, et al. · Pathology - Research and Practice · 10
Erfahrungen über Schußverletzungen der Nase und ihrer Nebenhöhlen
1916 · A. Zimmermann · European Archives of Oto-Rhino-Laryngology · 7
Prediction of human sensory irritation due to ethyl acrylate: the appropriateness of time-weighted average concentration × time models for varying concentrations
2017 · Stefan Kleinbeck, Michael Schäper, et al. · Archives of Toxicology · 6
Miners Compensated for Pneumoconiosis and Glutathione S -Transferases M1 and T1 Genotypes
2012 · Anna Zimmermann, Rainer Ebbinghaus, et al. · Journal of Toxicology and Environmental Health · 6
A phase II study of tasisulam sodium (LY573636) as second-line treatment for patients with unresectable or metastatic melanoma.
2010 · J. M. Kirkwood, R. Gonzalez, et al. · Journal of Clinical Oncology · 6
UROLOGICAL ONCOLOGY: BLADDER, PENIS AND URETHRA CANCER, AND BASIC PRINCIPLES OF ONCOLOGY Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
2006 · Hans von der Maase, L. Sengeløv, et al. · 2
Works count: 43
Citation count: 1,004
H-index: 17
I10-index: 20
Year
Topic
Type